Book Appointment Now
Contact Person
Mr. Thanikainathan A
(Vice President - Corporate Affairs & Company Secretary)
thanikainathan.a@dragarwal.com
044 – 4378 7777
For Investors
Dr. Agarwal's Health Care Limited
Dr. Agarwal’s Health Care Limited is one of India's oldest and largest eye-care networks, trusted for more than seven decades across India and Africa.
About Us
Dr. Agarwal’s Health Care Limited is one of India's oldest and largest eye-care networks, trusted for more than seven decades across India and Africa. With long standing operational history, we endeavor to address all the needs of our patients in their eye treatment journey through a network of facilities across India and nine countries in Africa.
We provide end-to-end comprehensive eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sells opticals, contact lenses and accessories, and eye care related pharmaceutical products.
01
Board Meeting Intimation - for Q2 FY 2026-27
02
Outcome of Board Meeting held on October 20, 2026 - Material Update on Scheme of Amalgamation with Dr. Agarwal's Eye Hospital Limited
03
Outcome of NRC Meeting - October 20, 2026
04
Newspaper Publication – FY 2026-27 – Q1 Results
05
Newspaper Publication – FY 2026-27 – Notice of AGM
06
Documents for Inspection - AGM 21.09.2026
07
Notice of AGM 21.09.2026
08
Reg 74(5) - SEBI (Depositories and Participants) Regulations, 2018 – Q2 – FY 2026-27
09
Reconciliation of Share Capital Audit Report – Q2 – FY 2026-27
10
Receipt of Sanction from the Hon'ble NCLT, Chennai Bench, towards the Scheme of Amalgamation between AEHL & AHCL
11
Transcript – Proceedings of the 16th AGM of the Company
12
Regulation 30 - Completion of Tenure of Mr. Sanjay Anand, Independent Director of the Company
13
Update on Investment in Orbit Nigeria
14
Closure of Trading Window – for Q2 FY 2026-27
15
Voting Results and Scrutinizer's Report
16
Outcome of the 16th Annual General Meeting
17
Letter providing web-link and QR code to the Shareholders – 16th AGM of the Company – September 21, 2026
18
Press Release - August 27, 2026 - Launch of World's First Pinhole Pupilloplasty (PPP) Centre by Dr. Agarwal's Eye Hospital Limited, a subsidiary of the Company
19
Monitoring Agency Report - Q1 FY 2027
20
Outcome of Board Meeting – August 04, 2026
21
Board Meeting Intimation – for Q1 FY 2026-27
22
Newspaper Advertisement - Notice of Hearing
23
Allotment of ESOP – July 09, 2026
24
Reconciliation of Share Capital Audit Report – Q1 – FY 2026-27
25
Reg 74(5) - SEBI (Depositories and Participants) Regulations, 2018 – Q1 – FY 2026-27
26
Summary of Proceedings of the NCLT Convened Secured Creditors Meeting of the Company
27
Voting results of the NCLT Convened Secured Creditors Meeting of the Company
28
Summary of Proceedings of the NCLT Convened Unsecured Creditors Meeting of the Company
29
Voting results of the NCLT Convened Unsecured Creditors Meeting of the Company
30
Voting results of the NCLT Convened Equity Shareholders Meeting of the Company
31
Summary of Proceedings of the NCLT Convened Equity Shareholders Meeting of the Company
32
Closure of Trading Window – for Q1 FY 2026-27
33
Joint Newspaper Advertisement of the NCLT convened meetings of shareholders and creditors
34
Letter providing weblink and QR Code
35
Notice convening the meeting of the Equity Shareholders
36
Notice convening the meeting of the Unsecured Creditors
37
Notice convening the meeting of the Secured Creditors
38
Annual Secretarial Compliance Report – FY 26
39
Update on Investment in Orbit Ethiopia
40
Disclosure under Regulation 30 read with Part A Para B of Schedule III to the SEBI (LODR) Regulations, 2015
41
Disclosure under Regulation 30 read with Part A Para B of Schedule III to the SEBI (LODR) Regulations, 2015
42
Monitoring Agency Report – Q4 FY 2026
43
Disclosure under Regulation 30 read with Part A Para B of Schedule III to the SEBI (LODR) Regulations, 2015
44
Allotment of ESOP – April 08, 2026
45
Reg 74(5) - SEBI (Depositories and Participants) Regulations, 2018 - Q4 – FY 2025-26
01
Board Meeting Intimation - for Q2 FY 2026-27
02
Outcome of Board Meeting held on October 20, 2026 - Material Update on Scheme of Amalgamation with Dr. Agarwal's Eye Hospital Limited
03
Outcome of NRC Meeting - October 20, 2026
04
Newspaper Publication – FY 2026-27 – Q1 Results
05
Newspaper Publication – FY 2026-27 – Notice of AGM
06
Documents for Inspection - AGM 21.09.2026
07
Notice of AGM 21.09.2026
08
Reg 74(5) - SEBI (Depositories and Participants) Regulations, 2018 – Q2 – FY 2026-27
09
Reconciliation of Share Capital Audit Report – Q2 – FY 2026-27
10
Receipt of Sanction from the Hon'ble NCLT, Chennai Bench, towards the Scheme of Amalgamation between AEHL & AHCL
11
Transcript – Proceedings of the 16th AGM of the Company
12
Regulation 30 - Completion of Tenure of Mr. Sanjay Anand, Independent Director of the Company
13
Update on Investment in Orbit Nigeria
14
Closure of Trading Window – for Q2 FY 2026-27
15
Voting Results and Scrutinizer's Report
16
Outcome of the 16th Annual General Meeting
17
Letter providing web-link and QR code to the Shareholders – 16th AGM of the Company – September 21, 2026
18
Press Release - August 27, 2026 - Launch of World's First Pinhole Pupilloplasty (PPP) Centre by Dr. Agarwal's Eye Hospital Limited, a subsidiary of the Company
19
Monitoring Agency Report - Q1 FY 2027
20
Outcome of Board Meeting – August 04, 2026
21
Board Meeting Intimation – for Q1 FY 2026-27
22
Newspaper Advertisement - Notice of Hearing
23
Allotment of ESOP – July 09, 2026
24
Reconciliation of Share Capital Audit Report – Q1 – FY 2026-27
25
Reg 74(5) - SEBI (Depositories and Participants) Regulations, 2018 – Q1 – FY 2026-27
26
Summary of Proceedings of the NCLT Convened Secured Creditors Meeting of the Company
27
Voting results of the NCLT Convened Secured Creditors Meeting of the Company
28
Summary of Proceedings of the NCLT Convened Unsecured Creditors Meeting of the Company
29
Voting results of the NCLT Convened Unsecured Creditors Meeting of the Company
30
Voting results of the NCLT Convened Equity Shareholders Meeting of the Company
31
Summary of Proceedings of the NCLT Convened Equity Shareholders Meeting of the Company
32
Closure of Trading Window – for Q1 FY 2026-27
33
Joint Newspaper Advertisement of the NCLT convened meetings of shareholders and creditors
34
Letter providing weblink and QR Code
35
Notice convening the meeting of the Equity Shareholders
36
Notice convening the meeting of the Unsecured Creditors
37
Notice convening the meeting of the Secured Creditors
38
Annual Secretarial Compliance Report – FY 26
39
Update on Investment in Orbit Ethiopia
40
Disclosure under Regulation 30 read with Part A Para B of Schedule III to the SEBI (LODR) Regulations, 2015
41
Disclosure under Regulation 30 read with Part A Para B of Schedule III to the SEBI (LODR) Regulations, 2015
42
Monitoring Agency Report – Q4 FY 2026
43
Disclosure under Regulation 30 read with Part A Para B of Schedule III to the SEBI (LODR) Regulations, 2015
44
Allotment of ESOP – April 08, 2026
45
Reg 74(5) - SEBI (Depositories and Participants) Regulations, 2018 - Q4 – FY 2025-26
46
Reconciliation of Share Capital Audit Report – Q4 – FY 2025-26
47
Regulation 30 - Update on Cessation of ‘Idearx’ as an Associate Company
48
Closure of Trading Window – for Q4 FY 2025-26
49
Monitoring Agency Report – Q3 FY 2026
50
Reconciliation of Share Capital Audit Report – Q3 – FY 2025-26
51
Reg 74(5) - SEBI (Depositories and Participants) Regulations, 2018_Q3 - FY 2025-26
52
Closure of Trading Window – for Q3 FY 2025-26
53
Regulation 30 – Change in Statutory Auditors
54
Monitoring Agency Report - Q2 FY 2026
55
Outcome of Board Meeting – October 30, 2025
56
Regulation 30 - Update on Acquisition of Aditya Jyoti
57
Reconciliation of Share Capital Audit Report – Q2 – FY 2025-26
58
Reg 74(5) - SEBI (Depositories and Participants) Regulations, 2018_Q2 - FY 2025-26
59
Regulation 30 - Update on Acquisition
60
Closure of Trading Window - Q2
61
Press Release - August 27, 2025
62
Monitoring Agency Report – Q1 FY 2026
63
Reconciliation of Share Capital Audit Report – Q1 – FY 2025-26
64
Reg 74(5) - SEBI (Depositories and Participants) Regulations, 2018_Q1 - FY 2025-26
65
Closure of Trading Window Q1
66
Commencement of Operations - New Delhi
67
Annual Secretarial Compliance Report - FY 25
68
Monitoring Agency Report - Q4 FY 2025
69
Reg 74(5) - SEBI (Depositories and Participants) Regulations, 2018
70
Commencement of New Branch - Eluru
71
Closure of Trading Window - Q4
72
Commencement of New Branch - Dombivli
73
Regulation 30 - Additional Details
74
Commencement of New Branch - Udhna
75
Regulation 30 - Orders
76
Commencement of New Branch - Gopalpatnam
77
Commencement of New Branch - Karimnagar
78
Commencement of New Branch - Virar
79
Commencement of New Branch - Mysore & Siddipet
80
Commencement of New Branch - Jaunpur
97
Notice of EGM 31-05-2022
98
Notice of EGM 18-04-2022
99
Outcome of NRC Meeting – May 21, 2026
100
Board Meeting Intimation – for Q4 FY 2025-26
101
Outcome of Board Meeting – February 03, 2026
102
Outcome of NRC Meeting – February 03, 2026
103
Board Meeting Intimation – for Q3 FY 2025-26
104
Allotment of ESOP - January, 06, 2026
105
Allotment of ESOP – December 12, 2025
106
Outcome of Board Meeting - October 30, 2025
107
Board Meeting Notice - Q2 results
108
Voting Results and Scrutinizer's Report
109
Outcome of the 15th Annual General Meeting
110
Outcome of Board Meeting - August 27, 2025
111
Board Meeting Notice - Q1 results
112
Board Meeting Notice - FY 25 Results
113
Allotment of ESOP - May 14, 2025
114
Reg 30 - SEBI (LODR) - Allotment of ESOP
115
Board Meeting Notice – Q3 Results FY 2024-25
116
Postal Ballot Notice – November 12, 2025
117
Newspaper Advertisement - Postal Ballot Notice and e-voting information
118
Voting Results – Postal Ballot Notice dated November 12, 2025
119
Newspaper publication FY 25-26 – Q1 Results
120
Newspaper Publication FY 25-26 – Notice of AGM
01
Familiarization 31.03.2026
02
Contact details of KMP as required under regulation 30(5) of the SEBI LODR, 2015
03
Familiarisation 31.03.2025
04
Employees Stock Option Scheme - 2022
05
Corporate Social Responsibility Policy
06
Nomination and Remuneration Policy
07
Policy on Materiality of Related Party Transactions and on Dealing with Related Party Transactions
08
Dividend Distribution Policy
09
Independent Director Familiarization Programmee
10
Policy for Determining Materiality Subsidiaries
11
Code of Conduct for Prevention of Insider Trading
12
Risk Management Policy
13
Vigil Mechanism-Whistle Blower Policy
14
Sexual Harassment Prevention Policy
15
Code of Conduct by Board of Directors and Senior Managerial Personnel
16
Policy on Succession planning for Board and Senior Management
17
Anti-Bribery and Anti-Corruption Policy
18
Policy on Board Evaluation and Performance
19
Policy on preservation of documents and archival policy for archiving data and documents
20
Policy on Board Diversity
21
Policy for Determining Materiality of Events
22
MOA and AOA
23
Disclosures under Regulation 46 of SEBI LODR, 2015
01
Certified Copy of the NCLT Sanction Order dated September 30, 2026
02
Order passed by the Hon’ble NCLT for service of notice to authorities
03
Press Release on Amalgamation
04
Investor Presentation on Amalgamation
05
Audited Financial Results (Consolidated & Standalone) for the quarter and year ended March 31, 2026
06
Certified Copy of the Order passed by the Hon’ble NCLT for convening the meetings of Shareholders and Creditors
07
Receipt of Order passed by the Hon’ble NCLT for convening the meetings of Shareholders and Creditors
08
Supplementary Accounting Statement (Unaudited) as on December 31, 2025
09
Receipt of Observation Letter with “no adverse observations” from BSE
10
Receipt of Observation Letter with “no objections” from NSE
01
Certified Copy of the NCLT Sanction Order dated September 30, 2026
02
Order passed by the Hon’ble NCLT for service of notice to authorities
03
Press Release on Amalgamation
04
Investor Presentation on Amalgamation
05
Audited Financial Results (Consolidated & Standalone) for the quarter and year ended March 31, 2026
06
Certified Copy of the Order passed by the Hon’ble NCLT for convening the meetings of Shareholders and Creditors
07
Receipt of Order passed by the Hon’ble NCLT for convening the meetings of Shareholders and Creditors
08
Supplementary Accounting Statement (Unaudited) as on December 31, 2025
09
Receipt of Observation Letter with “no adverse observations” from BSE
10
Receipt of Observation Letter with “no objections” from NSE
11
NSE Complaints Report- 10-10-2025
12
BSE Complaints Report- 09-10-2025
13
Detailed Compliance Report
14
Auditor's Certificate on Accounting Treatment
15
Fairness Opinion
16
Report of the Audit Committee
Got Questions? We've Got Answers!
thanikainathan.a@dragarwal.com
044 – 4378 7777
Investor Relations
Aashna Dharia
Head – Investor Relations
investor.relations@dragarwal.com
044 – 4378 7777
Investor Contacts & RTA Details
KFin Technologies Limited, Selenium Tower B, Plot 31-32, Gachibowli, Financial District, Nanakramguda, Hyderabad- 500 032, Telangana Toll-free No. 1800-309-4001
einward.ris@kfintech.com
+ 91 40 67161630